LIB Therapeutics Inc. (LIB), a privately held biopharmaceutical company with a singular focus on helping high-risk patients achieve their cholesterol goals, today announced the U.S. Food and Drug ...
A black box warning is the most serious from the U.S. Food and Drug Administration, and critics say there is no justification ...